Prevention of rhesus isoimmunization affecting pregnancy

**Prevention of rhesus isoimmunization affecting pregnancy** refers to the clinical strategy used to stop an Rh(D)-negative pregnant individual from mounting an immune response against Rh(D)-positive red blood cells This hematologic and immunologic complication occurs when fetomaternal hemorrhage exposes an unsensitized Rh-negative mother to paternally inherited Rh-positive fetal erythrocytes, triggering the production of maternal anti-D antibodies Prophylaxis aims to neutralize circulating feta...

**Prevention of rhesus isoimmunization affecting pregnancy** refers to the clinical strategy used to stop an Rh(D)-negative pregnant individual from mounting an immune response against Rh(D)-positive red blood cells

This hematologic and immunologic complication occurs when fetomaternal hemorrhage exposes an unsensitized Rh-negative mother to paternally inherited Rh-positive fetal erythrocytes, triggering the production of maternal anti-D antibodies In subsequent pregnancies, these maternal immunoglobulin G antibodies can cross the placenta and destroy fetal red blood cells, leading to hemolytic disease of the fetus and newborn, profound fetal anemia, hydrops fetalis, or intrauterine demise

In subsequent pregnancies, these maternal immunoglobulin G antibodies can cross the placenta and destroy fetal red blood cells, leading to hemolytic disease of the fetus and newborn, profound fetal anemia, hydrops fetalis, or intrauterine demise

In subsequent pregnancies, these maternal immunoglobulin G antibodies can cross the placenta and destroy fetal red blood cells, leading to hemolytic disease of the fetus and newborn, profound fetal anemia, hydrops fetalis, or intrauterine demise

Prophylaxis aims to neutralize circulating fetal Rh-positive antigens before maternal B-cell sensitization occurs, preserving maternal-fetal compatibility in current and future gestations